CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trade Dr. Martens plc - DOCS.L CFD

1.3690
10.23%
0.0440
Low: 1.347
High: 1.422
Market Trading Hours* (UTC) Opens on Friday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0440
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.023178 %
Charges from borrowed part ($-0.93)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.023178%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.00126 %
Charges from borrowed part ($0.05)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.00126%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency GBP
Margin 20%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

*Information provided by Capital.com

Dr Martens PLC ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 1.525
Open* 1.406
1-Year Change* -34.97%
Day's Range* 1.347 - 1.422
52 wk Range 1.27-2.95
Average Volume (10 days) 1.04M
Average Volume (3 months) 35.69M
Market Cap 1.56B
P/E Ratio 8.85
Shares Outstanding 1.00B
Revenue 957.00M
EPS 0.18
Dividend (Yield %) 1.99616
Beta -100.00K
Next Earnings Date Jun 1, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 31, 2023 1.5250 0.0250 1.67% 1.5000 1.5895 1.4800
May 30, 2023 1.5260 -0.0085 -0.55% 1.5345 1.5560 1.4570
May 26, 2023 1.5885 -0.0590 -3.58% 1.6475 1.6475 1.5505
May 25, 2023 1.6655 0.0840 5.31% 1.5815 1.6725 1.5815
May 24, 2023 1.6195 -0.0150 -0.92% 1.6345 1.6345 1.5645
May 23, 2023 1.6575 0.0320 1.97% 1.6255 1.6585 1.6225
May 22, 2023 1.6625 -0.0400 -2.35% 1.7025 1.7035 1.6505
May 19, 2023 1.7165 0.0200 1.18% 1.6965 1.7355 1.6945
May 18, 2023 1.7055 0.0220 1.31% 1.6835 1.7115 1.6725
May 17, 2023 1.6835 -0.0040 -0.24% 1.6875 1.6875 1.6415
May 16, 2023 1.6875 0.0120 0.72% 1.6755 1.6925 1.6745
May 15, 2023 1.6915 0.0400 2.42% 1.6515 1.6915 1.6475
May 12, 2023 1.6545 0.0080 0.49% 1.6465 1.6695 1.6365
May 11, 2023 1.6525 -0.0120 -0.72% 1.6645 1.6865 1.6375
May 10, 2023 1.6645 0.0200 1.22% 1.6445 1.6765 1.6335
May 9, 2023 1.6445 -0.0050 -0.30% 1.6495 1.6705 1.6305
May 5, 2023 1.6475 0.0240 1.48% 1.6235 1.6685 1.6045
May 4, 2023 1.6325 0.0160 0.99% 1.6165 1.6395 1.5675
May 3, 2023 1.6195 0.0030 0.19% 1.6165 1.6605 1.5875
May 2, 2023 1.6365 -0.0390 -2.33% 1.6755 1.6765 1.6245

Dr. Martens plc Events

Time (UTC) Country Event
Friday, July 14, 2023

Time (UTC)

08:30

Country

GB

Event

Dr Martens PLC Annual Shareholders Meeting
Dr Martens PLC Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, November 22, 2023

Time (UTC)

10:59

Country

GB

Event

Half Year 2024 Dr Martens PLC Earnings Release
Half Year 2024 Dr Martens PLC Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 908.3 773 672.2 454.4 348.6
Revenue 908.3 773 672.2 454.4 348.6
Cost of Revenue, Total 329.5 302.5 270.7 193.8 162.6
Gross Profit 578.8 470.5 401.5 260.6 186
Total Operating Expense 679 660.5 529.7 386.4 308.4
Selling/General/Admin. Expenses, Total 315.8 246.3 217 175.6 136
Depreciation / Amortization 36.7 33.9 28.9 9.8 5.6
Interest Expense (Income) - Net Operating -3.2 -3.8 0.5 1.2 1.4
Unusual Expense (Income) 0.2 81.6 12.6 6 2.8
Operating Income 229.3 112.5 142.5 68 40.2
Interest Income (Expense), Net Non-Operating -15 -41.6 -41.5 -39.1 -39.5
Net Income Before Taxes 214.3 70.9 101 28.9 0.7
Net Income After Taxes 181.2 35.7 74.8 17.2 -5.7
Net Income Before Extra. Items 181.2 35.7 74.8 17.2 -5.7
Net Income 181.2 35.7 74.8 17.2 -5.7
Income Available to Common Excl. Extra. Items 181.2 35.7 74.8 17.2 -5.7
Income Available to Common Incl. Extra. Items 181.2 35.7 74.8 17.2 -5.7
Diluted Net Income 181.2 35.7 74.8 17.2 -5.7
Diluted Weighted Average Shares 1002.9 1000.4 1000 1000 1000
Diluted EPS Excluding Extraordinary Items 0.18068 0.03569 0.0748 0.0172 -0.0057
Dividends per Share - Common Stock Primary Issue 0.055 0 0 0
Diluted Normalized EPS 0.18084 0.07676 0.08413 0.02077 -0.00388
Sep 2022 Mar 2022 Sep 2021 Mar 2021 Sep 2020
Total revenue 418.6 538.4 369.9 454.8 318.2
Revenue 418.6 538.4 369.9 454.8 318.2
Cost of Revenue, Total 160.8 186.2 143.3 170.6 131.9
Gross Profit 257.8 352.2 226.6 284.2 186.3
Total Operating Expense 353.3 377.8 301.2 407.1 253.4
Selling/General/Admin. Expenses, Total 169 178 137.8 146.3 100
Depreciation / Amortization 23.3 18.7 18 16.6 17.3
Interest Expense (Income) - Net Operating 0.2 -5.3 2.1 -3.9 0.1
Unusual Expense (Income) 0.2 0 77.5 4.1
Operating Income 65.3 160.6 68.7 47.7 64.8
Interest Income (Expense), Net Non-Operating -7.4 -7.6 -7.4 -18.7 -22.9
Net Income Before Taxes 57.9 153 61.3 29 41.9
Net Income After Taxes 44.7 132.6 48.6 6.2 29.5
Net Income Before Extra. Items 44.7 132.6 48.6 6.2 29.5
Net Income 44.7 132.6 48.6 6.2 29.5
Income Available to Common Excl. Extra. Items 44.7 132.6 48.6 6.2 29.5
Income Available to Common Incl. Extra. Items 44.7 132.6 48.6 6.2 29.5
Diluted Net Income 44.7 132.6 48.6 6.2 29.5
Diluted Weighted Average Shares 1004.7 1003.2 1002.6 1000.8 1000
Diluted EPS Excluding Extraordinary Items 0.04449 0.13218 0.04847 0.0062 0.0295
Dividends per Share - Common Stock Primary Issue 0.0156 0.0428 0
Diluted Normalized EPS 0.04449 0.13235 0.04847 0.05653 0.03239
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 443.6 274.8 277.2 165.5 169.3
Cash and Short Term Investments 228 113.6 117.2 58.4 86.4
Cash & Equivalents 228 113.6 117.2 58.4 86.4
Total Receivables, Net 87.6 56 65 48.9 36.7
Accounts Receivable - Trade, Net 75.9 50.7 55.5 40.8 29.7
Total Inventory 123 101.5 90 53.9 39.8
Prepaid Expenses 4.1 3.4 3.5 4.2 6.4
Other Current Assets, Total 0.9 0.3 1.5 0.1 0
Total Assets 859.1 652.8 656.5 450.2 445.8
Property/Plant/Equipment, Total - Net 143.8 110 114.7 26.9 23.6
Property/Plant/Equipment, Total - Gross 239 181.6 159.2 47.6 36.3
Accumulated Depreciation, Total -95.2 -71.6 -44.5 -20.7 -12.7
Goodwill, Net 240.7 240.7 240.7 240.7 240.7
Intangibles, Net 21.4 20.1 16.5 11.1 7.8
Other Long Term Assets, Total 9.6 7.2 7.4 6 4.4
Total Current Liabilities 155 152.3 130.7 64.5 55.6
Accounts Payable 52.4 52.6 33.4 20 19.6
Accrued Expenses 76.8 75.1 50.1 27.6 22.3
Notes Payable/Short Term Debt 0 0 20 0 0
Current Port. of LT Debt/Capital Leases 19.8 18.2 21.8 3.2 4.1
Other Current Liabilities, Total 6 6.4 5.4 13.7 9.6
Total Liabilities 530.9 502.1 586 458.6 475.2
Total Long Term Debt 374 348.2 453.8 387.5 416
Long Term Debt 280.9 281.6 387.2 387.5 416
Capital Lease Obligations 93.1 66.6 66.6 0 0
Other Liabilities, Total 1.9 1.6 1.5 6.6 3.6
Total Equity 328.2 150.7 70.5 -8.4 -29.4
Common Stock 10 10 0 0 0
Additional Paid-In Capital 0 0 10
Retained Earnings (Accumulated Deficit) 311.3 138.1 58.9 -15.9 -43.6
Treasury Stock - Common 0 0 0
Other Equity, Total 6.9 2.6 11.6 7.5 4.2
Total Liabilities & Shareholders’ Equity 859.1 652.8 656.5 450.2 445.8
Total Common Shares Outstanding 1000.22 1000 1000 1000 1000
Sep 2022 Mar 2022 Sep 2021 Mar 2021 Sep 2020
Total Current Assets 523.6 443.6 314 274.8 372.6
Cash and Short Term Investments 133 228 113.2 113.6 146.8
Cash & Equivalents 133 228 113.2 113.6 146.8
Total Receivables, Net 114.2 87.6 73.9 56 88.6
Accounts Receivable - Trade, Net 95.8 75.9 64.2 50.7 76.6
Total Inventory 261.4 123 119.8 101.5 128
Prepaid Expenses 8.5 4.1 6.7 3.4 5
Other Current Assets, Total 6.5 0.9 0.4 0.3 4.2
Total Assets 981.3 859.1 709.6 652.8 750.8
Property/Plant/Equipment, Total - Net 181.6 143.8 125.6 110 111
Property/Plant/Equipment, Total - Gross 239 212.2 181.6 170.9
Accumulated Depreciation, Total -95.2 -86.6 -71.6 -59.9
Goodwill, Net 240.7 240.7 240.7 240.7 240.7
Intangibles, Net 24.4 21.4 20.6 20.1 19.1
Other Long Term Assets, Total 11 9.6 8.7 7.2 7.4
Total Current Liabilities 218.9 155 140.2 152.3 183.5
Accounts Payable 105.7 52.4 46 52.6 83.5
Accrued Expenses 75.1 76.8 66.8 75.1 53.9
Notes Payable/Short Term Debt 0 0 0 0 20
Current Port. of LT Debt/Capital Leases 28.4 19.8 20 18.2 19.5
Other Current Liabilities, Total 9.7 6 7.4 6.4 6.6
Total Liabilities 634.8 530.9 506 502.1 650.4
Total Long Term Debt 410.6 374 364.1 348.2 465.3
Long Term Debt 292.9 280.9 285.3 281.6 396
Capital Lease Obligations 117.7 93.1 78.8 66.6 69.3
Other Liabilities, Total 4.5 1.9 1.7 1.6 1.6
Total Equity 346.5 328.2 203.6 150.7 100.4
Common Stock 10 10 10 10 0
Additional Paid-In Capital 0
Retained Earnings (Accumulated Deficit) 316.2 311.3 188.6 138.1 93.2
Treasury Stock - Common -0.6
Other Equity, Total 20.3 6.9 5 2.6 7.8
Total Liabilities & Shareholders’ Equity 981.3 859.1 709.6 652.8 750.8
Total Common Shares Outstanding 1000.56 1000.22 1000 1000 1000
Deferred Income Tax 0.8
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 181.2 35.7 74.8 17.2 -5.7
Cash From Operating Activities 184.4 160.2 121.4 56 46
Cash From Operating Activities 36.9 35 29.5 10.6 6.5
Non-Cash Items 17 49.3 42.4 41 34.2
Cash Taxes Paid 8.1 -2.1 8.3 0.4 -0.9
Cash Interest Paid 10.8 12.8 5.4 5.2 5.3
Changes in Working Capital -50.7 40.2 -25.3 -12.8 11
Cash From Investing Activities -25 -18.6 -21.9 -17.1 -16.4
Capital Expenditures -25 -18.6 -21.9 -17.1 -16.4
Other Investing Cash Flow Items, Total 0 0 0
Cash From Financing Activities -47 -132.9 -44 -69.3 -9.3
Financing Cash Flow Items -10.8 -12.8 -5.4 -5.2 -5.3
Issuance (Retirement) of Stock, Net 0 -303.6 -35 -60 0
Issuance (Retirement) of Debt, Net -24 183.5 -3.6 -4.1 -4
Foreign Exchange Effects 2 -12.3 3.3 2.4 -1.1
Net Change in Cash 114.4 -3.6 58.8 -28 19.2
Total Cash Dividends Paid -12.2
Sep 2022 Mar 2022 Sep 2021 Mar 2021 Sep 2020
Net income/Starting Line 44.7 181.2 48.6 35.7 29.5
Cash From Operating Activities -22.7 184.4 23.9 160.2 65.4
Cash From Operating Activities 23.3 36.9 18 35 18.4
Non-Cash Items 10.6 17 11.3 49.3 23
Cash Taxes Paid 0.9 8.1 7.9 -2.1 -1.7
Cash Interest Paid 4.2 10.8 4.3 12.8 4.9
Changes in Working Capital -101.3 -50.7 -54 40.2 -5.5
Cash From Investing Activities -19.3 -25 -10.1 -18.6 -11.6
Capital Expenditures -19.3 -25 -10.1 -18.6 -8.2
Other Investing Cash Flow Items, Total 0 -3.4
Cash From Financing Activities -57.6 -47 -15.8 -132.9 -22.3
Financing Cash Flow Items -4.2 -10.8 -4.3 -12.8 -4.9
Issuance (Retirement) of Stock, Net 0 0 -303.6 0
Issuance (Retirement) of Debt, Net -10.6 -24 -11.5 183.5 -17.4
Foreign Exchange Effects 4.6 2 1.6 -12.3 -1.9
Net Change in Cash -95 114.4 -0.4 -3.6 29.6
Total Cash Dividends Paid -42.8 -12.2
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Permira Advisers LLP Private Equity 36.3845 364142440 0 2022-05-31 LOW
GIC Private Limited Sovereign Wealth Fund 4.2114 42148324 0 2022-05-31 LOW
Artemis Investment Management LLP Investment Advisor/Hedge Fund 2.8333 28356330 14321519 2022-12-15 MED
T. Rowe Price Associates, Inc. Investment Advisor 2.1889 21907032 2696660 2022-12-15 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.7552 17566569 2732376 2023-05-01 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.7452 17465988 66870 2022-12-15 LOW
Jupiter Asset Management Ltd. Investment Advisor/Hedge Fund 1.5265 15277892 -634189 2022-12-12 LOW
Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund 1.4772 14784023 -126648 2022-12-12 LOW
Fidelity Management & Research Company LLC Investment Advisor 1.3997 14008399 -8677 2023-05-01 LOW
Wilson (Kenneth) Individual Investor 1.1213 11222226 178 2023-05-11 LOW
T. Rowe Price International Ltd Investment Advisor/Hedge Fund 1.1024 11033105 2278196 2022-12-15 MED
Franklin Mutual Advisers, LLC Investment Advisor/Hedge Fund 1.0793 10801883 3058257 2023-04-30 MED
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.0204 10211864 -37880 2023-05-01 LOW
Hargreaves Lansdown Fund Managers Ltd. Insurance Company 0.8567 8573590 1523884 2023-03-31 LOW
Martin Currie Investment Management Ltd. Investment Advisor/Hedge Fund 0.8274 8281098 636368 2022-12-15 LOW
M & G Investment Management Ltd. Investment Advisor 0.7923 7929521 -60098 2023-05-01 LOW
Mason (Paul) Individual Investor 0.7869 7875000 0 2022-03-31
Fidelity International Investment Advisor 0.7714 7720223 6221734 2023-05-01 LOW
Eurizon Capital SGR S.p.A. Investment Advisor/Hedge Fund 0.6875 6880893 281365 2022-12-12 MED
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.6601 6606478 4896 2023-05-01 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

535K+

Traders

87K+

Active clients monthly

$113M+

Monthly investing volume

$64M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Dr. Martens plc Company profile

About Dr Martens PLC

Dr. Martens plc is a United Kingdom-based company that designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Financial summary

BRIEF: For the six months ended 30 September 2021, Dr Martens PLC revenues increased 16% to £369.9M. Net income increased 65% to £48.6M. Revenues reflect Americas segment increase of 44% to £147.5M, Americas segment increase of 44% to £147.5M, Retail Sales - Total increase of 92% to £65.9M, Online Sales - Total increase of 10% to £82.6M. Net income benefited from Interest expense decrease of 75% to £5.1M (expense). Dividend per share totaled to £0.01.

Industry: Footwear (NEC)

28 Jamestown Rd
Camden
NW1 7BY

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

26,838.85 Price
-1.110% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00

XRP/USD

0.51 Price
-1.410% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00394

Oil - Crude

70.08 Price
+3.640% 1D Chg, %
Long position overnight fee -0.0204%
Short position overnight fee -0.0016%
Overnight fee time 21:00 (UTC)
Spread 0.03

Gold

1,977.31 Price
+0.700% 1D Chg, %
Long position overnight fee -0.0183%
Short position overnight fee 0.0101%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 535.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading